Furthermore, protein levels of APOE, A2M and TNFRSF11B were significantly up-regulated in the liver and plasma of NAFLD patients compared with the controls. This evidence concerns the gene TNFRSF11B and metabolic dysfunction-associated steatotic liver disease.